InMed Pharmaceuticals Stock (NASDAQ: INM) stock price, news, charts, stock research, profile.
You can purchase shares of InMed Pharmaceuticals (NASDAQ:INM) through any online brokerage.
There are no as such competitors for InMed Pharmaceuticals.
InMed Pharmaceuticals has a consensus price target of $6.00.
The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $4.7 last updated November 22, 2024 at 7:41 AM EST.
There are no upcoming dividends for InMed Pharmaceuticals.
InMed Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, February 11, 2025.
There is no upcoming split for InMed Pharmaceuticals.
InMed Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.